biotech · Advanced Solid Tumors · Seasonal Allergic Rhinitis · PRME
Prime Medicine
Prime Medicine clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 60 First St, Cambridge, Massachusetts 02141, US
- Founded
- 2019
- Employees
- 185
- Programs
- 17
- Drugs
- 6
- Patents
- 127
Prime Medicine projects
5 ClinicalTrials.gov programs sponsored by Prime Medicine.
Prime Medicine has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Bemarituzumab
Prime Medicine
Gastric Cancer
1 trial -
FP-1039
Prime Medicine
Endometrial Cancers With FGFR2 Mutations
1 trial -
FPA008
Prime Medicine
Pigmented Villonodular Synovitis
1 trial -
PM359
Prime Medicine
Chronic Granulomatous Disease
1 trial -
Pumecitinib Nasal Spray 0.3%
Prime Medicine
Seasonal Allergic Rhinitis
1 trial
Frequently asked questions
How many clinical projects does Prime Medicine have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.